Citation

Brunner J, Keck ME, Landgraf R, Uhr M, Namendorf C, Bronisch T. Eur. Neuropsychopharmacol. 2002; 12(5): 489-494.

Affiliation

Max Planck Institute of Psychiatry, Kraepelinstr. 2-10, D-80804, Munich, Germany. jBrunner@mpipsykl.mpg.de

Copyright

(Copyright © 2002, Elsevier Publishing)

DOI

unavailable

PMID

12208567

Abstract

Increased plasma arginine vasopressin (AVP) concentrations have been reported in depressed suicide attempters. Plasma AVP is primarily produced by the magnocellular system in response to increased plasma osmolality, and central AVP may be independently regulated. In the present study we investigated cerebrospinal fluid (CSF) and plasma AVP concentrations in depressed patients and controls. Nineteen drug-free depressed psychiatric inpatients (nine suicide attempters) and nine neurological control subjects underwent lumbar puncture and psychiatric evaluation. CSF and plasma concentrations of AVP, serotonin (5-HT), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and cortisol were assayed. In 15 depressed patients (eight suicide attempters), the combined dexamethasone/corticotropin-releasing hormone (Dex/CRH) test was performed to examine the hypothalamic-pituitary-adrenocortical (HPA) system. There were no differences between depressed subjects and controls in all parameters measured. Suicide attempters did not differ from nonattempters. In depressed patients, plasma AVP correlated positively with cortisol. There was no relationship between CSF AVP and monoamine metabolites in CSF.

Language: en